Natália Aniceto
Has grant
Professor of Pharmacokinetics
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Professor Natália Aniceto is a faculty member at the University of Lisbon, Portugal. Her research focuses on pharmacokinetics, particularly in the areas of ligand identification, enzyme inhibition, and drug discovery methodologies. Recent publications include studies on the automated identification of ligands, flavonoid modulators, and computational strategies for drug development against cancer.
Recent Grants
Grant: Close
ChemSlotProtein: Expanding the druggable universe to unlock chemists´ creativity
Open Date: 2022-01-17
Close Date: 2023-07-16
Grant: Close
Using a Genetic Algorithm to design new urease inhibitors
Open Date: 2022-01-10
Close Date: 2022-06-10
Grant: Close
Expanding the druggable target space
Open Date: 2020-01-01
Close Date: 2021-01-01
Articles (10)
Year:
2025
Year:
2025
Urease is a metalloenzyme that catalyzes the hydrolysis of urea, and its modulation has an important role in both the agricultural and medical industry. Even though numerous molecules have been tested against ureases of different species, their clinical translation has been limited due to chemical and metabolic stability as well as side effects. Therefore, screening new compounds against urease would be of interest in part due to rising concerns regarding antibiotic resistance. In this work, we collected and curated a diverse set of 2640 publicly available small-molecule inhibitors of jack bean urease and developed a classifier using a random forest machine learning method with high predictive performance. In addition, the physicochemical features of compounds were paired with molecular docking and protein–ligand fingerprint analysis to gather insight into the current activity landscape. We observed that the docking score could not differentiate active from inactive compounds within each chemical family, but scores were correlated with compound activity when all compounds were considered. Additionally, a decision tree model was built based on 2D and 3D Morgan fingerprints to mine patterns of the known active-class compounds. The final machine learning model showed good prediction performance against the test set (81% and 77% precision for active and inactive compounds, respectively). Finally, this model was employed, as a proof-of-concept, on an in-house library to predict new hits that were then tested against urease and found to be active. This is, to date, the largest, most diverse dataset of compounds used to develop predictive in silico models. Overall, the results highlight the usefulness of using machine learning classifiers and molecular docking to predict novel urease inhibitors.
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Collaborators (13)
Vasco Bonifácio
Assistant Professor
Instituto Superior Técnico
Rui Moreira
Full Professor
Faculty of Pharmacy, University of Lisbon
Hélio M. T. Albuquerque
Universidade de Aveiro
Eduarda Fernandes
Associate Professor
Universidade do Porto Faculdade de Medicina
Vera L. M. Silva
Universidade de Aveiro
Rita C. Guedes
Universidade de Aveiro
Joana Amaral
Assistant Professor
Universidade de Aveiro
Artur Silva
Full Professor
Universidade de Aveiro
Patrícia Serra
Assistant Professor/ Collaborator member of Egas Moniz Interdisciplinary Research Center
Egas Moniz Cooperativa de Ensino Superior CRL
M. Luísa Corvo
Vice-Dean
Universidade de Lisboa Faculdade de Farmácia
Romina Guedes
Invited Assistant Professor
Universidade de Lisboa Faculdade de Farmácia
Jorge A. R. Salvador
University of Coimbra
Nuno Martinho
Universidade de Aveiro
Make your next move.
Prepare your application
Review drafts before you send them.